Skip to main content
Home

GBL

Main navigation

  • About GBL
      About GBL
    • Our purpose
    • Shareholding
    • Governance
      • Board of Directors
      • Board Committees
      • Management
      • Organization
      • Corporate governance
    • ESG
      • Sustainability
      • GBL ACT
      • ESG glossary
    • Risk Management
    • Business model
  • Portfolio
      Portfolio
    • Listed assets
      • 63% of GBL’s portfolio
      • adidas
      • Concentrix
      • Imerys
      • Ontex
      • Pernod Ricard
      • SGS
      • Umicore
    • Private assets
      • 19% of GBL’s portfolio
      • Affidea
      • Canyon
      • Parques Reunidos
      • Sanoptis
      • Voodoo
    • Alternative assets
      • 17% of GBL’s portfolio
      • Funds
      • Co-investments
    • Third-party asset management
      • <1% of GBL’s portfolio
  • Investors
      Investors
    • GBL Share
      • Stock price & key share information
      • Dividend
      • Total Shareholder Return
      • Capital and form of shares
      • Voting rights and denominator
      • Transactions on GBL shares
    • Key Financial Information
      • Net asset value
      • Net financial position
      • Credit rating
      • Consolidated net result & Cash earnings
      • Glossary
    • Analysts
    • General Meeting
    • Financial Calendar
    • Strategic Update
    • Prospectus
  • Culture & Careers
  • Media Center
      Media Center
    • Press releases
    • Annual & Half-year reports
    • IR Presentations
    • Analyst Presentations
    • Voting rights and denominator
    • Transactions on GBL shares
    • Subscription Form
64.55 €
Stock price
12/20/202417:35
Governance

Corporate governance

Scroll to content

Corporate Governance Statement (Key data extracted from Annual Report 2022)

Read more

Corporate Governance Charter

Download

GBL's Articles of Association

Download

Code of Conduct

Download

Diversity and Inclusion Policy

Read more

Code of Conduct for Suppliers

Download

ESG Policy

Download

Main navigation

  • About GBL
      About GBL
    • Our purpose
    • Shareholding
    • Governance
      • Board of Directors
      • Board Committees
      • Management
      • Organization
      • Corporate governance
    • ESG
      • Sustainability
      • GBL ACT
      • ESG glossary
    • Risk Management
    • Business model
  • Portfolio
      Portfolio
    • Listed assets
      • 63% of GBL’s portfolio
      • adidas
      • Concentrix
      • Imerys
      • Ontex
      • Pernod Ricard
      • SGS
      • Umicore
    • Private assets
      • 19% of GBL’s portfolio
      • Affidea
      • Canyon
      • Parques Reunidos
      • Sanoptis
      • Voodoo
    • Alternative assets
      • 17% of GBL’s portfolio
      • Funds
      • Co-investments
    • Third-party asset management
      • <1% of GBL’s portfolio
  • Investors
      Investors
    • GBL Share
      • Stock price & key share information
      • Dividend
      • Total Shareholder Return
      • Capital and form of shares
      • Voting rights and denominator
      • Transactions on GBL shares
    • Key Financial Information
      • Net asset value
      • Net financial position
      • Credit rating
      • Consolidated net result & Cash earnings
      • Glossary
    • Analysts
    • General Meeting
    • Financial Calendar
    • Strategic Update
    • Prospectus
  • Culture & Careers
  • Media Center
      Media Center
    • Press releases
    • Annual & Half-year reports
    • IR Presentations
    • Analyst Presentations
    • Voting rights and denominator
    • Transactions on GBL shares
    • Subscription Form

Groupe Bruxelles Lambert (GBL)

Avenue Marnix 24
B-1000 Brussels

Contact

Reception
+32 2 289 17 86
cdumasy@gbl.com

Investor Relations

Alison Donohoe
+32 2 289 17 64
adonohoe@gbl.com
 

© 2024 GBL, all rights reserved

Footer Menu

  • Legal Notice
  • General Privacy Policy
  • Cookie policy

Made by Globule Bleu